. 2022 Dec 13;27(5):1461–1476. doi: 10.1177/13623613221140749

Table 4.

Means, standard deviations, statistical significance, and effect sizes between groups for ACT-related measures at pre, post, and 6-month follow-up.

Measure	n	Pre	Post	6 months	Group-by-time interaction effect (within-subjects)		Pre–post	Post 6 months
Measure	NeuroACT = 16 TAU = 18	M (SD)	M (SD)	M (SD)	ANOVA	d	d	d
AAQ	NeuroACT	30.4 (11.0)	23.9 (9.4)	21.6 (9.1)	F (2, 64) = 3.91	0.70^*	0.79^*	0.61
AAQ	TAU	30.4 (9.5)	29.8 (9.9)	28.7 (8.5)	F (2, 64) = 3.91	0.70^*	0.79^*	0.61
CFQ	NeuroACT	33.5 (11.4)	25.0 (9.4)	24.3 (8.0)	F (2, 64) = 5.32	0.82^**	1.07^**	0.35
CFQ	TAU	31.0 (9.2)	31.6 (9.9)	28.7 (8.8)	F (2, 64) = 5.32	0.82^**	1.07^**	0.35
CBAS	NeuroACT	82.1 (21.1)	67.0 (19.6)	65.3 (22.1)	F (2, 64) = 6.44	0.90^**	1.24^**	0.41
CBAS	TAU	80.7 (15.4)	86.5 (18.0)	80.7 (16.0)	F (2, 64) = 6.44	0.90^**	1.24^**	0.41

ANOVA: analysis of variance; AAQ: Acceptance and Action Questionnaire–7 items; CFQ: Cognitive Fusion Questionnaire–7 items; CBAS: Cognitive–Behavioral Avoidance Scale. Effect size measured by Cohen’s d (0.2 = small; 0.5 = moderate; 0.8 = large).

p < 0.05. **p < 0.01.